Author

E Frenkel

Observed names: E F Frenkel, Eugene Frenkel

Institutions: Guy's Hospital, Sarah Cannon Research Institute, King's College London, University of Cambridge, Shionogi (Japan), Institut Bergonié, The University of Texas Southwestern Medical Center

Observed institutions: Guy's Hospital, Sarah Cannon Research Institute, King's College London, University of Cambridge, Shionogi (Japan), Institut Bergonié, University of Pennsylvania, The University of Texas Southwestern Medical Center

OpenAlex ID: A5038782869

Ifosfamide: should the honeymoon be over?

1995 · B A Kamen, E Frenkel, et al. · Journal of Clinical Oncology · 40

Seven-week continuous-infusion paclitaxel plus concurrent radiation therapy for locally advanced non-small cell lung cancer: a phase I study.

1997 · D I Rosenthal, O Okani, et al. · PubMed · 12

Abstract P4-14-26: Phase I expansion of S-222611, a reversible inhibitor of EGFR and HER2, in advanced solid tumors, including HER2-positive breast cancer patients with brain metastases

2016 · RD Baird, H-T Arkenau, et al. · Cancer Research · 1

Abstract LB-85: Ectopic expression of eukaryotic translation elongation factor eEF1A2 is a hallmark for human lung cancer and is associated with poor prognosis

2012 · Xiao-Yun Liu, Wei Zhang, et al. · Cancer Research

Works count: 4

Citation count: 53

H-index: 2

I10-index: 2